Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
|Videos|March 19, 2016
Inappropriate Equianalgesic Conversions When Performing Opioid Rotations
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses the problems related to inappropriate equianalgesic conversions when performing opioid rotations.
Advertisement
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses the problems related to inappropriate equianalgesic conversions when performing opioid rotations.
This video was recorded at APhA's 2016 Annual Meeting and Exhibition in Baltimore, Maryland.
Advertisement
Related to this article
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
September’s pain management coverage examined postoperative nonopioid options, lessons from sickle cell pain research, and pharmacists’ experiences with controlled-substance prescribing.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1c reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
In a FINE-HEART analysis, cancer history raised the risk of death and hospitalization but did not blunt finerenone's cardiovascular and kidney benefits.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Intensive Chemotherapy in Combination With Quizartinib Versus Midostaurin for FLT3-ITD Mutated Acute Myeloid Leukemia: A Multicenter Cohort Study
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Orforglipron Edges Oral Semaglutide 25 mg in T2D, Indirect Comparison Finds
4
Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity
5